An array of prescription medications on shelves

Vaccines: A Case for Public Pharma

April 3, 2020
Expanding democratic ownership

Vaccines are critical to safeguarding public health as one of the most effective ways to prevent disease, including highly contagious diseases that can cause pandemics. But the for-profit pharmaceutical industry is neither prepared for nor incentivized to tackle growing public health challenges, like global pandemics.

The downloadable 1 page PDF below, produced in cooperation with the Center for Popular Democracy, makes the case for why we need public pharma to help combat pandemic threats like COVID-19.

Download and read now:

More related work
Illustration courtesy of United Nations

All health is public health: Busting the myths of choice and commodity

by Dana Brown

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. But the COVID-19

read more
June 3, 2021
A federal resolution calls for a shift to public power. Image by andreas160578 from Pixabay

Bush-Bowman congressional resolution calls for a shift to public power

by Johanna Bozuwa

The resolution by Reps. Cori Bush and Jamaal Bowman shows how we can replace the privatized, fossil-fueled, and racist energy system that we live with today with a public and community-controlled energy system that is rooted in justice.

read more
May 12, 2021
Default Image

New York needs “a public option” in electricity to meet climate and equity goals, report says

by Isaiah J. Poole

NEWS RELEASE: The New York State Build Public Renewables Act would make the New York Power Authority a major developer of renewable energy in the state and a key consumer energy provider.

read more